Enhanced motivation to take drugs is a central characteristic of addiction, yet the neural underpinning of this maladaptive behavior is still largely unknown. Here, we report a D1-like dopamine receptor (DRD1)-mediated long-term potentiation of GABA A -IPSCs (D1-LTP GABA ) in the oval bed nucleus of the stria terminalis that was positively correlated with motivation to self-administer cocaine in rats. Likewise, in vivo intra-oval bed nucleus of the stria terminalis DRD1 pharmacological blockade reduced lever pressing for cocaine more effectively in rats showing enhanced motivation toward cocaine. D1-LTP GABA resulted from enhanced function and expression of G-proteinindependent DRD1 coupled to c-Src tyrosine kinases and required local release of neurotensin. There was no D1-LTP GABA in rats that self-administered sucrose, in those with limited cocaine self-administration experience, or in those that received cocaine passively (yoked). Therefore, our study reveals a novel neurophysiological mechanism contributing to individual motivation to self-administer cocaine, a critical psychobiological element of compulsive drug use and addiction.
Introduction
Animal models believed to have a behavioral phenotype with face validity for human drug addiction display specific maladaptive behaviors such as enhanced motivation to take drugs, an inability to refrain from drug seeking, and maintained drug use despite adverse consequences (Deroche-Gamonet et al., 2004; Vanderschuren and Everitt, 2004) . These maladaptive behaviors can be investigated in the rat drug self-administration model using a progressive ratio (PR) schedule of drug reinforcement, perseverant drug-seeking measures, and resistance of drug self-administration to aversive suppression, respectively (Deroche-Gamonet et al., 2004; Vanderschuren and Everitt, 2004; Belin et al., 2008) . In the PR schedule of reinforcement, for example, enhanced effort is required to receive subsequent drug infusions (Deroche-Gamonet et al., 2004; Vanderschuren and Everitt, 2004; Belin et al., 2008) . Despite these advances in experimental models of addiction, the underlying neural mechanisms are still largely unknown. Here, we combined behavioral testing of cocaine selfadministration under a PR schedule of reinforcement, brain slice electrophysiology, in situ immunohistochemistry, and in vivo behavioral pharmacology to identify the potential neural mechanism(s) underlying increased motivation to cocaine use in rats.
Recently, we reported a reversal in dopamine (DA) modulation of GABA A synaptic transmission that was uniquely associated with prolonged cocaine self-administration and protracted withdrawal (Krawczyk et al., 2011a) . We detected DRD1-mediated increase in GABA A -IPSCs in the oval region of the dorsolateral bed (dl) nucleus of the stria terminalis (ovBNST). The ovBNST is densely innervated by DA-containing axons. Most drugs of abuse trigger robust DA release in this region in vivo and local DRD1 blockade reduces cocaine-and ethanol-mediated reinforcement in rats (Epping-Jordan et al., 1998; Carboni et al., 2000; Eiler et al., 2003) . Furthermore, dlBNST blockade of GABA A receptors reduces drug reinforcement, which is consistent with our observed DRD1-mediated increase in GABA A transmission measured in cocaine-self-administering rats (Hyytiä and Koob, 1995) . It is currently unknown whether the BNST contributes in enhanced motivation to seek and take drugs, but functional lesions of the dlBNST area reduce the motivation to struggle and escape in forced-swim tests (Schulz and Canbeyli, 2000; Pezük et al., 2006) . In addition, dlBNST deep brain stimulation reduces schedule-induced polydipsia in rats, a rodent model of obsessive-compulsive behaviors that reflects certain aspects of compulsive drug intake involving both DA and GABA synaptic transmission (Lopez-Grancha et al., 2008; van Kuyck et al., 2008) .
Here, we hypothesized that variation in DRD1-mediated increase in GABA A -IPSC serves as an important neural correlate for rats' motivation to self-administer cocaine. We report that after a prolonged cocaine self-administration experience, DRD1-mediated increase of ovBNST GABA A -IPSC was largely irreversible, revealing a long-term potentiation of GABA synapses (D1-LTP GABA ). D1-LTP GABA amplitude and in vivo response to intra-ovBNST DRD1 blockade was positively linked with individual lever pressing magnitude on the PR schedule. D1-LTP GABA resulted from de novo expression of postsynaptic DRD1 positively coupled to c-Src tyrosine kinases (TKs) in a G-proteinindependent way and required local neurotensin release. Our results reveal a novel neuromodulatory mechanism for DA that is specific to prolonged cocaine intake and may further encode individual motivation to self-administer cocaine in rats.
Materials and Methods
Animals. One hundred and twenty male Long-Evans rats (Charles River Laboratories) weighing 250 -300 g were included in the study. The rats were maintained on a 12 h reversed light/dark cycle (9:00 A.M. lights off/9:00 P.M. lights on) with all behavioral testing done during the dark cycle. The rats were allowed to acclimatize for a minimum of 7 d upon arrival to the facility. Rat chow and water were provided ad libitum in the home cages and in the test chambers for the duration of the experimental sessions. All experiments were conducted in accordance with the Canadian Council on Animal Care guidelines for use of animals in experiments and approved by the Queen's University Animal Care Committee. Eighty-nine rats implanted with indwelling catheters for intravenous cocaine administration were included in the study. Fourteen of these rats also had intracranial guide-cannulas implanted for intra-BNST or intracerebroventricular (ICV) microinjections. Eight rats implanted with intra-BNST guide-cannulas only were also included in the study.
Surgeries. Rats were weighted and anesthetized with isoflurane (2-3%, 5 L/min). Manufactured indwelling catheters were used for intrajugular cannulations (Model IVSA28Ј Camcath). The end of the tubing was inserted 32 mm into the right jugular vein toward the right atria and tied with 4.0 suturing silks. The rest of the tubing was fed subcutaneously to a back-mounted 28 Ga cannula. All incisions were closed with 4 -0 absorbable suturing silk. Upon surgery completion and recovery from anesthesia, rats were returned to the colony room. The rats received Anafen (5 mg/kg) injections subcutaneously, for 3 d postoperatively and also received fruits to supplement normal chow diet during recovery. IV cannulas were flushed daily with a sterile heparin-saline solution (20 IU heparin/ml) to prevent clots and conserve patency. Rats assigned to intra-ovBNST or ICV pharmacological manipulations were placed in a stereotaxic instrument and secured by nonrupture ear bars under isoflurane anesthesia (2-3%, 5 L/min). Double guide cannulas (Plastics One) were bilaterally implanted into the oval region of the dorsal BNST (Ϫ0.26 A.P., Ϯ1.9 M.L., Ϫ6.5 D.V.) or ICV (Ϫ0.26 A.P., Ϯ1.9 M.L., Ϫ4.5 D.V.). All stereotaxic coordinates were relative to bregma (Paxinos and Watson, 2005) . The head attachment was secured in place via four autoclaved 0.08 ϫ 0.125 inch jeweler screws and dental acrylic cement. To protect from pathogens and to ensure patency, the guide cannulas were fitted with an autoclaved 30 Ga stylet and covered with a screw-on cap.
Acquisition of instrumental operant behaviors. Behavioral testing for sucrose or cocaine self-administration was conducted in operant chambers, each equipped with a house light, a response lever with a cue light, and a food dispenser for sucrose pellet reinforcement (Med Associates). Rats were placed in the operant chambers for daily 4 h sessions. Rats learned sucrose-or cocaine-reinforced operant responding on a fixed ratio-1 (FR-1) schedule where each lever press illuminated the cue light and delivered the reward, either one sucrose pellet (75 mg) or a cocaineHCl infusion (0.75 mg/kg in 0.12 ml of sterile saline over 4 s). Upon each reward delivery, the lever was retracted for 20 s, during which the cue light remained illuminated; no additional responses could occur during this holding period. Training was considered acquired when the rats responded 25 times in a titrated fashion (infusions or pellet delivery at regular time intervals) for 3 consecutive days. All rats without health or catheter patency issues acquired cocaine self-administration successfully (5.1 Ϯ 0.2 d, n ϭ 65). Rats systematically acquired sucrose selfadministration behavior in 3 d.
Intracranial behavioral pharmacology. Upon reaching criteria for acquisition, rats assigned to maintenance of sucrose or cocaine selfadministration graduated to a PR schedule of reinforcement in which lever pressing to obtain each subsequent reward increased according to the following equation: response ratio ϭ 5e (injection number ϫ 0.2) Ϫ 5 ( Richardson and Roberts, 1996) . Final ratio pressing was used as the dependent variable in the PR schedule of reinforcement. Final ratio pressing was defined as the last bout of lever pressing required to reach breakpoint (BP). BP is the last reward received within a 60 min time period (Richardson and Roberts, 1996) . Therefore, rats received intra-BNST microinjections upon reaching stable responding over a period of 3 d (i.e., when log final ratio pressing was within 8% deviation of a 3 d average). The rats received 0.5 l per side intra-BNST or ICV microinjections of sterile saline 0.9% (vehicle) or SCH-23390 immediately before the behavioral sessions. All the rats in the intra-ovBNST group included in the study received a total of 4 microinjections: vehicle and 3 doses of SCH-23390 (0.4, 0.8, 1.6 g/l/side). Four (1 sucrose, 3 cocaine) supplementary rats were included Figure 1d to obtain a statistically reliable correlation analysis. These rats may not have received all doses of SCH-23390 and had to be removed from the dose-response experiments to satisfy a two-way mixed-model ANOVA (see Statistical analyses section). Rats in the ICV group only received vehicle and the highest dose of SCH-23390 (1.6 g/l/side). All microinjections occurred between days 15 and 60 of cocaine or sucrose self-administration on the PR schedule (Fig. 1a) . Doses of SCH were chosen according to recent work in the striatum, hippocampus, and amygdala (Andrzejewski et al., 2005; Pezze et al., 2007) . Drugs were delivered over a 90 s interval using a syringe pump (Razel Scientific Instruments). Drugs were blindly assigned following a pseudorandom schedule. The rats were visually monitored and no observable motor impairment or drowsiness was detected. Lever pressing and reward delivery data were acquired with MedPC-IV and analyzed with SoftCR-IV (Med Associates). Cannula placements were verified at the end of the experiments with microinjections of fluorescent microspheres (fluorospheres of carboxylate-modified microspheres, 0.04 m, 0.5 l per side; Invitrogen) over a 90 s interval using a syringe pump to verify the absence of ICV leaks in the intra-ovBNST group. The spread of fluorescent microspheres is shown in Figure 1f as an indication of cannula placement rather than an indication of drug diffusion. To increase bilateral placement accuracy, double-guide cannula mounts and a straight descend approach were used, inevitably traversing the lateral ventricles. Only rats with correct placement and absence of ICV fluorescent beads were included in the study (n ϭ 10 cocaine and 8 sucrose).
Experimental groups for electrophysiology. Rats were assigned to 5 experimental groups: Control (nϭ14), Sucrose (n ϭ 10), Cocaine Acquisition (n ϭ 9), Cocaine Maintenance (n ϭ 56), and Cocaine Yoked (n ϭ 8). Rats in the Control group were singly housed and age-matched to behaviorally trained rats. Rats in the Cocaine Acquisition group were killed for recordings 20 h after reaching criteria for acquisition of cocaine self-administration. Rats assigned to maintenance (Sucrose and Cocaine Maintenance) self-administration graduated to the PR schedule of reinforcement for a period spanning 15-53 d upon reaching criteria for acquisition and were also killed 20 h after their last self-administration session. A broad range of numbers of days of the PR schedule was used for the Cocaine Maintenance group to match as closely as possible the cocaine experience of the rats included in the behavioral pharmacology experiments. Cocaine Yoked rats were included in the study to dissociate the neural mechanisms underlying drug-taking behavior from the neural adaptations produced by chronic exposure to cocaine (Krawczyk et al., 2011a (Krawczyk et al., , 2011b . Accordingly, Cocaine Yoked rats received cocaine in exactly the same amount and frequency as their self-administering Cocaine Maintenance counterparts. Levers were not available but reward delivery was also signaled by a 20 s cue light illumination. Cocaine Yoked rats were killed for electrophysiology experiments the day before their Cocaine Main-tenance counterparts. One supplementary cocaine self-administration group was added to facilitate the interpretation of the results obtained with the Cocaine Maintenance group. These rats (n ϭ 3) remained on the FR-1 schedule of reinforcement for 15 d after the acquisition phase and were killed for electrophysiological recordings 20 h after their last self-administration procedure. This group was treated separately in the interest of clarity.
Slices preparation and electrophysiology. The rats were deeply anesthetized with isoflurane (5% at 5 L/min) and their brains rapidly removed and kept in ice-cold physiological solution containing the following (in mM): 126 NaCl, 2.5 KCl, 1.2 MgCl 2 , 6 CaCl 2 , 1.2 NaH 2 PO 4 , 25 NaHCO 3 , and 12.5 D-glucose equilibrated with 95% O 2 /5% CO 2 . The brains were cut into coronal slices (250 m) with a vibrating microtome (VT-1000; Leica) in the physiological solution maintained at 2°C throughout the slicing procedure. Slices containing the BNST were incubated at 34°C for at least 60 min and transferred to a chamber that was constantly perfused (3 ml/min) with the physiological solution maintained at 34°C. Whole-cell voltage-clamp recordings were made using glass microelectrodes (3.5 M⍀) filled with a solution containing the following (in mM): 70 K ϩ -gluconate, 80 KCl, 1 EGTA, 5 HEPES, 2 MgATP, 0.3 GTP, and 1 P-creatine. E Cl in these conditions was ϳϪ32 mV such that evoked GABA A postsynaptic responses were inward currents when neurons were voltage clamped at Ϫ70 mV. Detailed methodology for recordings of ovBNST GABA A -IPSC was described previously (Krawczyk et al., 2011a) . Postsynaptic GABA A currents were evoked by local fiber stimulation with tungsten bipolar electrodes in the presence of the AMPA antagonist DNQX (50 M). There was no measurable NMDA-EPSC in these conditions. Electrodes were placed in the ovBNST 100 -500 m dorsal from the recorded neurons and paired electrical stimuli (10 -100 A, 0.1 ms duration, 20 Hz) were evoked at 0.1 Hz. All drugs were bath applied through the perfusion system or, in many cases, included in the internal solution. Recordings were made using a Multiclamp 700B amplifier and a Digidata 1440A (Molecular Devices). Data were acquired and analyzed with Axograph X running on Apple computers.
Immunohistochemical detection of DRD1. Seven rats (3 Control, 4 Cocaine Maintenance) were deeply anesthetized with sodium chloral hydrate (400 mg/kg, i.p.) and perfused transcardiacally with 50 -100 ml of 0.9% NaCl followed by 300 ml of fixative consisting of 2% PFA with 0.2% glutaraldehyde in 0.1 M PB, pH 7.4. Brains were quickly removed, left overnight in 2% PFA at 4°C, and cut into 60-m-thick coronal slices with a vibrating blade microtome (VT1000S; Leica). To enhance the penetration of the immunoreagents, the sections were equilibrated in a cryoprotectant solution (0.05 M PB, pH 7.4, containing 25% sucrose and 10% glycerol), freeze-thawed, and stored in PBS with 0.03% sodium azide until needed. DRD1 was detected by immunohistochemistry according to previously described and validated procedures (Berthet et al., 2009 ) using a monoclonal antibody raised in rat against a 97 aa sequence corresponding to the C terminus of the human DRD1 (SigmaAldrich). Brain slices containing the ovBNST were incubated in 4% NGS or in normal donkey serum in PBS for 1 h at room temperature (RT) and then in the DRD1 antibody (1:1000) supplemented with 1% NGS or normal donkey serum overnight at RT. After washing (3 ϫ 10 min) in PBS, the sections were incubated in goat anti-rat IgG coupled to biotin (1:200 in PBS for 1.5 h; GE Healthcare). After three rinses (3 ϫ 10 min) in PBS, the sections were then incubated in avidin-biotin complex (1: 200, Vector ABC Elite; Vector Laboratories) in PBS for 1.5 h at RT and again rinsed (3 ϫ 10 min) in PBS. The immunoreactive sites were revealed by a combination of the glucose oxidase DAB (0.05% in Trizma buffer; Sigma-Aldrich) method and the DAB-nickel method. The reaction was stopped by several washes in H 2 O. The sections were mounted on glass slides, dehydrated, and mounted in Eukitt (Electron Microscopy Sciences). Negative immunohistological control demonstrated the Figure 1 . Effect of intra-ovBNST DRD1 blockade on sucrose and cocaine self-administration. a, Schedule for oral sucrose or intravenous cocaine self-administration (0.75 mg/ml/injection). S-A, self-administration. b, Effect of intra-ovBNST or ICV microinjections of the DRD1 antagonist SCH-23390 on sucrose or cocaine self-administration on final ratio pressing (top), time to reach breaking point (BP, middle), and time to reach 1 ⁄2 BP (bottom). Asterisks indicate significant difference compared with vehicle, p Ͻ 0.05. c, Representative experiments showing the effect of intra-ovBNST SCH-23390 (1.6 g/side, solid lines) compared with baseline (dotted lines) on sucrose (left) and cocaine (right) self-administration. Oblique tick marks indicate reward deliveries. BPs defined as described in the Materials and Methods are circled for each presented conditions. d, Left: Effect of SCH (1.6 g/side) compared with vehicle on final ratio pressing for cocaine in each rat tested. Right: Correlation between SCH (1.6 g/side)-induced reduction in final ratio pressing and magnitude of final ratio pressing for cocaine. Each dot represents data from one rat. Dotted lines indicate 95% confidence interval. e, Sum of fluorescent microspheres spread (dark gray areas) summarizing successful placements from which data were used in b. f, Representative histological location of a typical microinjection of fluorescent microspheres seen in bright-or dark-field microscopy. Schematics of coronal brain sections are adapted from Paxinos and Watson (2005) . Lv, lateral ventricles; ac, anterior commissure; ic, internal capsule.
absence of signal when omitting the primary antibody. The number of DRD1-immunopositive neurons in ovBNST was analyzed from immunoperoxidase-treated sections using an image analysis system (Mercator version 2.10, Explora Nova). At least three sections per rat were analyzed by an examiner blinded to experimental conditions. Densitometric analysis of perimembrane area of 100 DRD1-positives neurons was performed using the same image analysis system in the whole ovBNST. This measure was exclusively performed in neuron sections where the nucleus was clearly distinguishable.
D1R qPCR. RNA extracts from isolated ovBNST were purified with RNeasy Plus Micro Kit (QIAGEN), samples were treated with DNase (RNase-Free DNase Set; QIAGEN). The quality and quantity of the RNA samples were tested on a Model 2100 bioanalyzer with the RNA 6000 Pico LabChip Kit (Agilent Technologies). Quality was evaluated using the RNA Integrity Number value introduced by Agilent Technologies. A total of 3.5 ng of RNA was retrotranscribed to cDNA at 50°C with reverse transcriptase (Fermentas) in the presence of 1 l of random primer (150 ng/l) and 0.5 l of oligodt (200 ng/l). Real-time PCR was performed on a Light Cycler 480 (Roche) in a total volume of 10 l using 0.2 ng cDNA as templates, 3 l mixed forward and reverse primers (D1R: forward CGCGTAGACTCTGAGATTCTGAATT, reverse GAGTTAAGGA GCCACCACATCAGT), and 5 l of mixture 2 X Roche containing Fast Start TaqDNA polymerase reaction buffer dNTP mix (with dUTP instead of dTTP), Sybr Green I dye, and MgCl 2 . Relative expression of each gene was normalized respect to two different endogenous housekeeping control genes (Gapdh and Sdha; Gapdh: forward GAATGGGAAGCTGG TCATCAAC, reverse CCATTTGATGTTAGCGGGATCT; Sdha: forward TGCGGAAGCACGGAAGGAGT, reverse CTTCTGCTGGCCCT CGATGG) determined using the algorithm Genorm. The PCR data were exported in Gene Expression Analysis Software Environment (Inserm U862) for further analysis. The cycle point value of D1R was normalized against that of Sdha and Gapdh, and the relative level of expression was calculated using the comparative 2 Ϫ ⌬⌬Ct method.
Drugs. Stock solutions of DA (10 mM), quinpirole (1 mM), neurotensin (1 mM), and SCH-23390 (10 mM) were prepared in double-distilled water. Stock solution of DNQX (100 mM), SKF-81297 (1 mM), sulpiride (1 mM), U-73122 (10 mM), GTP-␤-s (10 mM), H89 (10 mM), PP2 (10 mM), PP3 (10 mM), genistein (10 mM), daidzein (10 mM), and SR 14298 (10 mM) were prepared in DMSO (100%). All drugs were further dissolved in the physiological solutions at the desired concentrations and the final DMSO concentration never exceeded 0.1%. Cocaine-HCl was dissolved at 2.5 mg/ml in sterile saline 0.9% and the pH was adjusted to 7.3 with NaOH (1 N). For microinjection experiments, SCH-23390 was dissolved in sterile saline 0.9% at 0.8, 1.6, and 3.2 g/l. Drugs were obtained from Sigma-Aldrich or Tocris Biosciences except cocaine-HCl, which was obtained from Medisca.
Statistical analyses. Drug-induced changes in postsynaptic current peak amplitude were measured from baseline and are shown as percentages as follows: (Peak amplitude drug Ϫ Peak amplitude baseline /Peak amplitude baseline ) * 100. Data are reported as means Ϯ SEM. In graphs where time courses of drug effects are presented, each data point is the average of 1 min bins (6 evoked GABA A -IPSCs) across recorded neurons. Therefore, data points are repeated measures but are still represented as means Ϯ SEM. In such cases, SEM is presented to provide a visual indication of the variability across neurons, but no statistical conclusions were made from this variability measure. Paired-pulse ratios (PPRs) were calculated by dividing the second (S2) by the first (S1) peak amplitude. PPRs were compared before and after drug application using paired t tests. Peak amplitudes for S1 and S2 were calculated from a baseline value measured immediately before the stimulus artifacts; in cases where S1 did not fully decay, the baseline for S2 differed from that of S1 (for in-depth discussion of this issue, see Krawczyk et al., 2011a Krawczyk et al., , 2011b . The coefficient of variation (CV) by plotting r [(CV baseline 2 )/(CV DRD1
2 )] against (Peak amplitude DRD1 /Peak amplitude baseline ) and computed bivariate linear fits of r by (Faber and Korn, 1991) . ANOVAs were used to compare multiple means and the appropriate statistical tests for multiple comparisons conducted when ANOVAs deemed significance. All statistics from the within-subjects ANOVAs were reported using the Greenhouse-Guesser correction for violations in sphericity, and degrees of freedom for Greenhouse-Giesser values are rounded up to the nearest whole number. Followup analysis for interactions on the betweensubjects variables were evaluated with simple main effect analyses and independent samples pairwise t tests. To control for type I error rates across multiple comparisons, a Bonferroni correction was applied to all p-values unless otherwise stated. All statistical analyses were done with JMP 10.0 (SAS Institute).
Results
OvBNST DRD1 signaling is positively linked with motivation to self-administer cocaine We previously reported a switch from DRD2-to DRD1-mediated modulation of GABA A -IPSC in ovBNST neurons of cocaine-self-administering rats (Krawczyk et al., 2011a) . To determine the behavioral significance of this alteration in DA receptor signaling, we tested the hypothesis here that intra-ovBNST DRD1 blockade would be more effective in subjects reaching higher BPs on the PR schedule of reinforcement for cocaine. We also measured the effects of intra-ovBNST DRD1 pharmacological blockade on sucrose self-administration and hypothesized that the DRD1 antagonist SCH-23390 would be mostly ineffective because there is no measurable DRD1-mediated increase in GABA A -IPSC in these rats (Krawczyk et al., 2011a) .
Bilateral intra-ovBNST microinjections of SCH-23390 (0.4, 0.8, and 1.6 g/side) interfered with cocaine, but not sucrose, self-administration on a PR schedule of reinforcement ( Fig. 1b,  top; Fig. 1c ; Group ϫ Dose of SCH interaction: F (3,11) ϭ 3.1, p ϭ 0.001). SCH-23390 also dose-dependently reduced time to reach BP in cocaine self-administering rats ( Fig. 1b, middle ; Group ϫ Dose of SCH interaction: F (3,11) ϭ 1.81, p ϭ 0.008). Bilateral ICV microinjections of SCH-23390 (1.6 g/side) were ineffective at interfering with cocaine self-administration ( Fig. 1b; final ratio pressing, t 3 ϭ 0.1, p ϭ 0.1; time to reach BP, t 3 ϭ 0.7, p ϭ 0.5). SCH-23390 also dose-dependently increased the rate of lever pressing in the reward-rich portion of cocaine (time to reach 1 ⁄2 BP in minutes), but not sucrose self-administration (Fig. 1b , bottom; Group ϫ Dose of SCH interaction: F (3,11) ϭ 1.2, p ϭ 0.03). This shows that SCH-23390 most likely reduced BP on the PR schedule by reducing the reinforcing property of cocaine (as shown previously shown by Epping-Jordan et al., 1998) and not through motor impairment or precipitated fatigue. SCH-23390 1.6 g/side did not affect the time to reach 1 ⁄2 BP when given ICV (Fig. 1b , bottom right; t 3 ϭ 0.8, p ϭ 0.5). SCH-23390 at the highest tested concentration (1.6 g) was more potent at reducing lever pressing in rats reaching higher BP, suggesting that the DRD1 in the dlBNST may contribute to the exaggerated motivation to self-administer cocaine that certain individuals displayed on the PR schedule (Fig. 1d) . Therefore, SCH-23390-induced reduction in lever pressing for cocaine was positively correlated with BP magnitude that individual rats reached on the PR schedule of reinforcement ( Fig. 1d ; Spearman's ϭ 0.8, p ϭ 0.01).
Prolonged cocaine self-administration experience reveals DRD1-mediated LTP of ovBNST GABA synapses We next determined whether in vivo pharmacological blockade of ovBNST DRD1 is related to the in vitro D1-mediated increase in GABA A -IPSC we measured previously in rats with a cocaine self-administration experience (Krawczyk et al., 2011a) . We further sought to determine whether DRD1-mediated increase in GABA A -IPSC was specific to prolonged cocaine self-administration by comparing this response in brain slices prepared from five groups of rats: (1) age-matched and naive to any behavioral procedures or drug exposure (Control), (2) with a prolonged (20 -30 d) sucrose self-administration experience on the PR schedule of reinforcement (Sucrose), (3) trained to acquire operant responding for cocaine on an FR-1 schedule of reinforcement (Cocaine Acquisition), (4) with a prolonged (15-53 d) cocaine self-administration experience (Cocaine Maintenance), or (5) yoked to Cocaine Maintenance rats that received cocaine in exactly the same amounts and frequency (Cocaine Yoked) ( Fig.  2a and see Materials and Methods for in-depth description and justification of experimental groups). Twenty hours after the last self-administration session, we prepared brain slices for wholecell voltage-clamp recordings to measure the effect of DRD1 activation on ovBNST GABA A -IPSC. We activated DRD1 by briefly (5 min) bath applying the DRD1-like agonist SKF-81297 (1 M) or coapplying DA (1 M) and the DRD2 antagonist sulpiride (10 M) and measured the change in amplitude of electrically evoked GABA A -IPSC (Fig. 2) . SKF (Fig. 2c) or the combination of DA and sulpiride (Fig. 2d ) had little effect on GABA A -IPSC amplitude in ovBNST neurons of Control, Sucrose, Cocaine Acquisition, or Cocaine Yoked rats, confirming the virtual absence of functional ovBNST DRD1 in these conditions (also see Krawczyk et al., 2011a Krawczyk et al., , 2011b . In contrast, both SKF (ϩ125.4 Ϯ 22.5%, Fig. 2c ; Time ϫ Group interaction, F (12,47) ϭ 8.12, p Ͻ 0.0001) and DA/sulpiride (ϩ98.5 Ϯ 10.8%, Fig. 2b,d ; Time ϫ Group interaction, F (12,52) ϭ 3.9, p ϭ 0.0003) produced a long-lasting increase in GABA A -IPSC amplitude in Cocaine Maintenance rats. DA (1 M) also produced a sustained increase of GABA A -IPSC in Cocaine Maintenance, but not in Cocaine Yoked rats, in the absence of DRD2 blockade, but this was of smaller amplitude (ϩ23.1 Ϯ 5.06%; Krawczyk et al., 2011a) . This shows that DRD2 blockade was not necessary to measure a sustained increase in GABA A -IPSC but rather experimentally amplified the response, facilitating the investigation of the underlying mechanisms. SKF also produced a long-lasting increase in GABA A -IPSC amplitude (ϩ134.5 Ϯ 7.1%, n ϭ 8 neurons in 3 rats) in a group of rats that, in contrast to the Cocaine Maintenance group, remained on the reward-rich schedule (FR-1) for 15 d after the acquisition phase. This confirms our previous observation that the switch from D2DR to D1DR control of GABA transmission in the ovBNST of cocaineself-administering rats is not due to the transition from a rewardrich to reward-lean schedule (Krawczyk et al., 2011a) .
The increase in GABA A -IPSC amplitude largely outlasted washing SKF or DA out of the bath and, accordingly, we refer to this response as DRD1-dependent LTP of GABA A -IPSC (D1-LTP GABA ). In some neurons where extended high-quality wholecell recordings were obtained, D1-LTP GABA was still sustained for tens of minutes (Fig. 2e shows the data from 2 neurons with a 55 min postwash period). Preapplication of the DRD1 competitive antagonist SCH-23390 (10 M) completely prevented D1-LTP GABA , confirming that DA acted through D1-like DA receptors (Fig. 2e, right) . Conversely, applying SCH-23390 at the plateau of D1-LTP GABA (chaser) was ineffective, suggesting that transient DRD1 activation was sufficient to trigger self-sustaining mechanisms supporting LTP GABA (Fig. 2e, middle; D1-LTP GABA was accompanied by a significant reduction (SKF; t 9 ϭ Ϫ4.7, p ϭ 0.001, DA/sulpiride; t 12 ϭ Ϫ6.4, p Ͻ 0.0001) in PPR (PPR 50 ms ), suggesting an increase in the presynaptic probability of GABA release (Fig. 2b,f; Zucker, 1989 ). CV analysis, taken as an index of neurotransmitter release fidelity as a function of change in response amplitude, confirmed that the expression of D1-LTP GABA was most likely presynaptic ( Fig. 2g ; Spearman's ϭ 0.7, p ϭ 0.0003; Faber and Korn, 1991). Therefore, interevent amplitude variability decreased monotonically with DRD1-induced enhancement in GABA A -IPSC amplitude, indicative of facilitation in presynaptic GABA release (Faber and Korn, 1991; Krawczyk et al., 2011a Krawczyk et al., , 2011b . Presynaptic expression of D1-LTP GABA is thus consistent with activity-dependent LTP GABA in other brain regions, a mechanism that involves enhanced probability of GABA release yet requires postsynaptic release of a retrograde messenger (e.g., nitric oxide; Nugent et al., 2008) .
Because intra-ovBNST SCH-23390-induced reduction in lever pressing for cocaine was positively correlated with BP magnitude that individual rats reached on the PR schedule of reinforcement (Fig. 1d,e) , we hypothesized that the amplitude of D1-LTP GABA may also positively correspond to the rat's motivation to self-administer cocaine. Indeed, the magnitude of DRD1-mediated increase in GABA A -IPSC was positively related with BP on the PR schedule of cocaine reinforcement ( Fig. 2h ; Spearman's ϭ 0.7, p ϭ 0.01), supporting a putative mechanism underlying individual motivation to self-administer cocaine in rats. In contrast, the increase in GABA A -IPSC amplitude was not related to the number of days rats spent on the PR schedule ( Fig. 2i ; Spearman's ϭ 0.2, p ϭ 0.64). The data reveal a novel neural mechanism that may underlie the exaggerated motivation to self-administer cocaine certain rats display on the PR schedule of reinforcement. Therefore, we investigated further the cellular and molecular mechanisms responsible for the DRD1-mediated enhancement of ovBNST GABA A -IPSC. Given the clear lack of DRD1 activity in Sucrose, Cocaine Acquisition, and Cocaine Yoked rats, we narrowed the comparison to Control versus Cocaine Maintenance rats for the remainder of the study.
Prolonged cocaine self-administration experience enhanced ovBNST DRD1 expression
The ovBNST of Control rats is very low in DRD1, both anatomically (Fig. 3a,b ,e,f ) and functionally ( Fig. 2 ; Krawczyk et al., 2011a Krawczyk et al., , 2011b . We thus hypothesized that cocaine selfadministration was accompanied by increased expression of DRD1, a phenomenon observed in the striatum of parkinsonian rats or macaque monkeys exposed to chronic DA replacement therapy and in macaque monkeys with a prolonged but not limited cocaine self-administration experience, three well characterized hyperdopaminergic conditions (Nader et al., 2002; Guigoni et al., 2007; Berthet et al., 2009 ). We detected DRD1 by immunohistochemistry using a monoclonal antibody raised in the rat against a 97 aa sequence corresponding to the C terminus of the human DRD1 (Sigma-Aldrich; Levey et al., 1993) . We confirmed a very low level of DRD1 in the ovBNST of Control rats (Fig.  3a,b) . In contrast, DRD1 were easily detectable in perikarya and proximal dendrites of ovBNST neurons of Cocaine Maintenance rats (Fig. 3d) . The DRD1 cellular distribution was qualitatively and quantitatively modified by the cocaine self-administration with a robust increase in the number of DRD1-expressing neurons ( Fig. 3e ; t 5 ϭ 2.4, p ϭ 0.003) and in the perimembranous DRD1 optical density of those ovBNST neurons ( Fig. 3f ; t 6 ϭ 4.1, p Ͻ 0.0001). This result suggests active accumulation and anchoring of the DRD1 nearby or at the plasma membrane in cocaine-self-administering rats. The lack of transcriptomic changes affecting DRD1 (qPCR fold change in D1 mRNA between Control: 1.08 Ϯ 0.08 vs Cocaine Maintenance: 0.95 Ϯ 0.09, p ϭ 0.37) is consistent with the acute transcriptomic effects of hyperdopaminergia where proteins can accumulate over time (Aubert et al., 2005; Berthet et al., 2009) . The data of Figure 3 suggest that D1-LTP GABA resulted from enhanced expression of functional DRD1 in the ovBNST occurring with prolonged selfadministration of cocaine that seem, however, to be located in the postsynaptic compartment. Although enhanced DRD1 immunohistochemical product is consistent with the robust D1-LTP GABA , the postsynaptic location seems inconsistent with the presynaptic locus of expression for D1-LTP GABA , which is presynaptic (Fig.  2f,g ). Therefore, we hypothesized the involvement of an extracellular signaling molecule(s) linking postsynaptic functional DRD1 with presynaptic enhancement of GABA release.
Local neurotensin release links postsynaptic DRD1 with presynaptic LTP GABA
The ovBNST is exclusively populated with GABA neurons that colocalize corticotropin releasing factor (CRF), neurotensin, or enkephalin, which we predicted could all be released locally in response to DRD1 activation and modulate synaptic transmission (Day et al., 1999) . CRF increases GABA A -IPSC amplitude in the dlBNST, albeit through a postsynaptic mechanism, dampening its potential role in D1-LTP GABA (Kash and Winder, 2006) . Furthermore, opioid receptor activation reduces GABA transmission in the BNST (Dumont and Williams, 2004; Li et al., 2012) . In contrast, neurotensin triggers GABA release in several brain regions, including the rodent prefrontal cortex, striatum, globus pallidus, and hippocampus Rakovska et al., 1998; Petrie et al., 2005) . Here, bath application of neurotensin (1 M) transiently enhanced GABA A -IPSC amplitude in ovBNST neurons with equal effectiveness in slices from Control and Cocaine Maintenance rats (Fig. 4a , main effect of time [Control] , F (2,7) ϭ 8.6, p ϭ 0.01; main effect of time [Cocaine] , F (2,4) ϭ 8.4, p ϭ 0.04; Time ϫ Group, F (4,19) ϭ 2.6, p ϭ 0.08). In Cocaine Maintenance rats, the effect of neurotensin was presynaptic because the PPR 50 ms decreased significantly ( Fig.  4b,c ; t 11 ϭ Ϫ4.1, p ϭ 0.001), supporting its putative role in D1-LTP GABA . To verify that DRD1 activation may cause local neurotensin release, we sought to determine whether postsynaptic depolarization could trigger a neurotensin-dependent increase in GABA A -IPSC. Repetitive depolarization (from Ϫ70 to 0 mV for 100 ms at 2 Hz for 5 min) produced a robust and reversible increase in GABA A -IPSC amplitude ( Fig. 4d,e; ϩ87.8 Ϯ 27.6%, main effect of time, F (2,11) ϭ 8.5, p ϭ 0.006). Bath application of the broad-spectrum neurotensin receptor (NTS1 and 2) antagonist SR-14298 (10 M) significantly reduced this response, suggesting that indeed a train of depolarization pulses triggers neurotensin release in the ovBNST ( Fig. 4d ; Time ϫ Group, F (3,43) ϭ 5.0, p ϭ 0.005). Similar to the pharmacological application of neurotensin, paired-pulse analyses suggested that depolarization-induced enhancement of GABA A -IPSC was presynaptic ( Fig. 4e,f ; t 6 ϭ Ϫ4.1, p ϭ 0.006). Therefore, it is likely that postsynaptic DRD1 activation triggers local neurotensin release, which then enhances the probability of GABA release and an increase in GABA A -IPSC amplitude. We thus predicted that the NTS antagonist would prevent D1-LTP GABA in slices prepared from Cocaine Maintenance rats, which was indeed the case ( Fig. 4g,h ; p ϭ 0.0001 vs DRD1 activation alone). Although the effect of neurotensin lasted several minutes, the amplitude of GABA A -IPSC inevitably returned to baseline (Fig. 4a,d ). How- Fig. 2c,d ). Dotted lines indicate 95% confidence interval. i, DRD1-induced change in GABA A -IPSC amplitude (time 25-30 min) as a function of the number of days that individual rats spent on the PR schedule of cocaine reinforcement. Each symbol (SKF, squares; DA, circles) represents the average of all neurons from a single rat (n ϭ 12, same dataset as in Fig. 2c,d ). Dotted lines indicate 95% confidence interval. ever, the kinetic of this response suggested little desensitization such that a sustained release of neurotensin could potentially support D1-LTP GABA . Accordingly, and unlike DRD1 signaling, which we previously showed to be irreversible once activated (Fig. 2e) , we predicted that we could chase D1-LTP GABA with a competitive NTS antagonist. As predicted, GABA A -IPSC returned to baseline within 15 min of bath application of SR-14298 at the peak of D1-LTP GABA ( Fig. 4g,h; F (2,14) ϭ 30.4, p Ͻ 0.0001). This experiment further supports sustained DRD1 signaling, resulting in a prolonged release of neurotensin that may trigger, per se, reversible intracellular signaling in the presynaptic GABA terminal. In addition, neurotensin was equally efficacious at increasing GABA A -IPSC in slices from Control and Cocaine Maintenance rats (Fig. 4a) , such that we predicted that D1- LTP GABA in Cocaine Maintenance rats resulted from mechanistic alterations upstream from NTS receptors activation. Accordingly, we next examined the signaling pathway recruited by DRD1 activation with pharmacological manipulations of the postsynaptic compartment by adding drugs in the recording (internal) solution, avoiding direct interference with putative presynaptic NTS signaling.
DRD1-LTP GABA involves c-Src TK signaling in a G-protein-independent fashion
The incorporation of various pharmacological blockers of signaling molecules and enzymes significantly interfered with D1-LTP GABA , confirming the postsynaptic location of DRD1 signaling and the specific pathways involved (main effect of pharmacological blockers on D1-LTP GABA amplitude at time 20 -25 min; F (7,54) ϭ 5.01, p ϭ 0.0002, Fig. 5 ). These data suggest that DRD1 coupled to intracellular signaling pathways that are, perhaps, self-sustaining once activated. There is little evidence that intracellular signals typically recruited by DRD1, such as adenylate cyclase/PKA or the PLC/PKC pathways (for review, see Neve et al., 2004) , would support such a phenomenon. Accordingly, the addition of the PKA inhibitor H89 (10 M) or the PLC inhibitor U-73122 (10 M) to the intracellular solution did not affect D1-LTP GABA (Fig. 5; Dunnett's Method, p ϭ 0.7 and 0.8, respectively) . In contrast, H89 and U-73122 blocked DA-mediated modulation of NMDAR-currents in these same neurons and conditions, confirming their efficacy at the chosen concentration, but also that DRD1 engages multiple signaling pathways to differently modulate excitatory and inhibitory transmission in these conditions (data not shown). D1-LTP GABA occurred despite the intracellular presence of the nonhydrolyzable GTP analog GDP-␤s (250 M), suggesting G-protein-independent DRD1 ( Fig. 5 ; Dunnett's Method, p ϭ 0.9). We confirmed the efficacy of GDP-␤s at this concentration by blocking DRD2-mediated modulation of GABA A -IPSC (data not shown) and D1/DRD2-mediated modulation of NMDA-EPSC (data not shown) in these same neurons and conditions.
In contrast to serine/threonine kinases, TKs typically contribute to long-lasting, self-sustaining biological responses (for review, see Luttrell et al., 1999a) . Specifically, c-Src TKs contribute to the DRD1-induced increase in GABA A -IPSC and trigger inhibitory oscillations in the mouse lateral amygdala in a putative G-protein-independent way (Lorétan et al., 2004) . Here, the intracellular presence of the nonspecific TK inhibitor genistein (10 M) or the specific c-Src TK inhibitor PP2 (10 M) completely blocked D1-LTP GABA in Cocaine Maintenance rats ( Fig. 5 ; Dunnett's Method, p ϭ 0.02 and 0.005, respectively), whereas daidzein (10 M) and PP3 (10 M), inactive analogs of genistein and PP2, respectively, were ineffective ( Fig. 5 ; Dunnett's Method, p ϭ 0.9 and 0.8, respectively). Therefore, this series of experiments revealed the involvement of c-Src TK but also confirmed an obligatory role for postsynaptic activation of DRD1 in D1-LTP GABA because intracellular pharmacological manipulations effectively blocked the response. Naturally, this series of experiments relies upon the specificity of all the pharmacological agents used, but we obtained several negative results, which reduces substantially the possibility of nonspecific effects.
Discussion
Brain slice voltage-clamp recordings of neurons in the ovBNST revealed DA DRD1-mediated long-lasting increases in GABA A -IPSC amplitude (D1-LTP GABA ) specifically in rats with prolonged cocaine self-administration experience. D1-LTP GABA resulted from increased GABA release involving local release of neurotensin after postsynaptic activation of G-proteinindependent and c-Src-dependent DRD1. Intra-ovBNST DRD1 blockade and D1-LTP GABA magnitude were positively linked with lever pressing for cocaine on a PR schedule of reinforcement, revealing a novel neurophysiological mechanism of individual motivation to self-administer cocaine in rats (Fig. 6) . ovBNST D1-LTP GABA in the maintenance of cocaine self-administration behaviors Our data suggest that ovBNST D1-LTP GABA may represent a mechanism underpinning the highest segment of lever pressing under the PR schedule of cocaine reinforcement. In an individual-sensitive way, this mechanism reveals a potential neural substrate of at least one defining element of compulsive cocaine intake in rats (Deroche-Gamonet et al., 2004; Vanderschuren and Everitt, 2004; Belin et al., 2008) . ovBNST D1-LTP GABA was not detectable after acquisition of cocaine self-administration, which may rule out its involvement in instrumental learning and in the response-outcome phase of instrumental operant behavior (Everitt and Robbins, 2005) . Conversely, ovBNST D1-LTP GABA seemed critical in the maintenance of cocaine self-administration once putatively switched to a more stimulus-response (S-R) scheme observed with prolonged training (Everitt and Robbins, 2005; Vanderschuren et al., 2005) . DA signaling did not change with prolonged maintenance of sucrose self-administration, suggesting that sucrose-driven operant behavior may not strictly switch to S-R in our conditions. Therefore, ovBNST D1-LTP GABA may add a positive reinforcing signal energizing the S-R driven behavior (Robinson and Berridge, 1993) . This would suggest that S-R driven cocaine intake might not be dissociated from the incentive value of rewards (Robinson and Berridge, 1993). "Energized" S-R driven drug seeking and taking may support the switch to compulsive drug use in certain individuals and ovBNST DRD1 signaling might be an underlying mechanism. This hypothesis is supported by enhancement of lever pressing for cocaine on reward-rich schedules (initial portion of daily PR schedule in Fig. 1b, bottom; Fig. 1c , right; and Epping-Jordan et al., 1998) for the effect of intradlBNST SCH-23390 on FR-1) with intra-dlBNST DRD1 blockade and is indicative of a reduction in the reinforcing property of the reward. Although ovBNST D1-LTP GABA is not restricted to a low contingency schedule of reinforcement, its magnitude seems critical in driving enhanced motivation to seek cocaine in the low contingency portion of the PR schedule of reinforcement (Epping-Jordan et al., 1998; Krawczyk et al., 2011a) . Furthermore, ovBNST D1-LTP GABA may also contribute in relapse to cocaine seeking, because 30 d of withdrawal did not reverse ovBNST DRD1 function (Krawczyk et al., 2011a) . Whether the ovBNST contributes to the reinforcing properties of cocaine through positive or negative reinforcement (or both processes) is unclear and will necessitate further investigations (Koob and Le Moal, 2008) .
Cocaine self-administration alters ovBNST DA receptor expression and function
Corroborating results from our previous study, we observed here that prolonged cocaine self-administration, but not similar passive exposure to cocaine, was accompanied by robust alterations in DA receptor expression and function in the ovBNST (Krawczyk et al., 2011a) . Under normal (physiological) conditions, the primary synaptic effect of DA in the ovBNST is to reduce GABA release through the activation of presynaptic DRD2 (Krawczyk et al., 2011a (Krawczyk et al., , 2011b . This DRD2 response becomes dysfunctional in rats with a prolonged cocaine self-administration experience, which is consistent with observations made in striatal regions across several species, including humans (Volkow et al., 1993; Nader et al., 2006) .
In rats with a prolonged cocaine self-administration experience, our experiments show a reversal in DA-mediated modulation of GABA A currents, from reduction to enhancement, through a robust shift toward DRD1-mediated signaling over DRD2 (Krawczyk et al., 2011a) . Our functional and anatomical data show weak levels of DRD1 in the ovBNST of Control rats, suggesting transcriptional or posttranscriptional events resulting in enhanced expression of DRD1 in Cocaine rats. However, we measured comparable levels of DRD1 mRNA, suggesting posttranslational events consistent with other hyperdopaminergic conditions (Aubert et al., 2005; Berthet et al., 2009 ).
D1-LTP GABA involves local neurotensin release
PPR measures and CV analyses both confirmed our previous conclusions that DRD1-mediated enhancement of ovBNST GABA A -IPSC in Cocaine Maintenance rats results from an increase in presynaptic GABA release (Krawczyk et al., 2011a) . This observation challenged our initial prediction that interactions between DRD1 and GABA A could occur postsynaptically. This prediction was made from three observations: (1) in Cocaine Maintenance rats, we detected DRD1 immunohistochemical products in perikarya and primary dendrites of ovBNST neurons (Fig. 3) ; (2) applications of certain pharmacological agents into the postsynaptic compartment completely blocked D1-LTP GABA (Fig. 5) ; and (3) tyrosine phosphorylation of GABA A channels increased currents in heterologous and primary culture models (Wan et al., 1997) . Despite overwhelming evidence for a presynaptic expression of D1-LTP GABA but postsynaptic anatomical location of DRD1, we tested the alternative hypothesis for the involvement of a retrograde synaptic messenger. Our results Figure 6 . DA modulation of ovBNST GABA A -IPSC before and after cocaine self-administration. In the ovBNST of Control rats, DA binds to presynaptic DRD2 and decreases GABA release, resulting in a reversible reduction in GABA A -IPSC amplitude (Krawczyk et al., 2011a (Krawczyk et al., , 2011b . With a prolonged cocaine self-administration experience, presynaptic DRD2 receptors are substituted with postsynaptic DRD1 and DRD2 (Krawczyk et al., 2011b) . The resulting effect of postsynaptic activation of DRD1 and DRD2 is DRD1-LTP GABA , which involves c-Src-dependent release of neurotensin that increases presynaptic GABA release.
show that neurotensin links postsynaptic DRD1 activation with presynaptic enhancement of GABA release. Although our data confirm that postsynaptic depolarization can trigger neurotensin release, we cannot determine whether this release is somatodendritic or axonal because the ovBNST contains short-axon neurons such that neurotensin could be released synaptically at the axon terminal to contact presynaptic GABA terminals (LarrivaSahd, 2006) . Alternatively, somatodendritic release of neurotensin would support recent evidence that synaptic retrograde messaging is not solely restricted to small liposoluble molecules (e.g., NO, endocannabinoids) but can also be carried by neuropeptides. Nonetheless, our experiments show that neurotensin can act as a local modulator of synaptic transmission (Rakovska et al., 1998; Petrie et al., 2005) . However, ovBNST NT mRNA levels are under positive mesolimbic DA regulation such that an enhancement of NT levels may be at play in Cocaine Maintenance rats (Day et al., 2002) . The abolition of D1-LTP GABA by an NTS antagonist suggests that neurotensin is an important contributor in the maintenance of cocaine self-administration behaviors. Accordingly, many studies examining the link between neurotensin and the behavioral effects of drugs of abuse suggest an enhancing effect of neurotensin on the reinforcing properties of psychostimulants (Ervin et al., 1981; Lopak and Erb, 2005; Torregrossa and Kalivas, 2008) .
c-Src TKs underlie the long-lasting profile of ovBNST D1-LTP GABA Upon brief DRD1 activation, DRD1 ligands were no longer required to sustain D1-LTP GABA . Specifically, we showed that preapplying the DRD1 antagonist SCH-23390 prevented D1-LTP GABA , whereas SCH could not reverse it once initiated. This suggests that the mechanism(s) underlying the long-lasting profile of D1-LTP GABA most likely occurs downstream of DRD1 activation. Because the effect of neurotensin on GABA release was transient (Fig. 4a) , we suspected that c-Src activation might be the self-sustaining element in the sequence of signaling events. Consistent with this hypothesis, c-Src TK activity is selfsustaining through autophosphorylation of Tyr418 (for review, see Boggon and Eck, 2004) . Moreover, recent evidence supports a role for these enzymes in drug-driven behaviors (Narita et al., 2006) . Metabotropic receptors, including DRD1, can trigger intracellular signaling independently of G-proteins (Lee et al., 2002; Lorétan et al., 2004; Wang et al., 2008) . To investigate the contribution of G-protein in D1-LTP GABA , we used the nonhydrolyzable GTP analog GDP-␤s intracellularly in the micromolar range (Kotecha et al., 2002; Martina and Bergeron, 2008) . GDP-␤s was potent in our preparation because it completely blocked DRD2-dependent modulation of GABA A -IPSC and DRD1/DRD2-dependent modulation of NMDA-EPSC in the same ovBNST neuronal population and identical conditions when applied intracellularly (i.e., in the postsynaptic compartment, data not shown). G-protein-independent signaling often occurs through protein-protein interaction processes (Luttrell et al., 1999b; Kim et al., 2004) . Because there is no evidence of direct proteinprotein interaction between metabotropic receptors and c-Src TK, adaptor proteins (e.g., arrestins) may link DRD1 with c-Src activity (Luttrell et al., 1999b; Macey et al., 2005) .
Our study reveals a complex rearrangement in DA signaling and a complete reversal in DA modulation of GABA A -mediated synaptic transmission with a prolonged cocaine self-administration experience. Accordingly, DA in the ovBNST seems to completely change neurophysiological allegiance from a powerful physiological DRD2-mediated reduction (in GABA A synaptic transmission) to a longlasting enhancement in GABA A transmission mediated by DRD1 in cocaine self-administering rats. Above a certain magnitude, the DRD1-mediated response becomes significant in underlying the maladaptive enhanced effort certain rats are willing to spend to obtain cocaine on the PR schedule of reinforcement. Therefore, our study revealed a novel and complex neural mechanism that may play a critical role in at least one aspect of compulsive cocaine intake in rats and may contribute to addictive behaviors. Future studies should investigate the possible contribution of ovBNST D1-LTP GABA in other elements of compulsive cocaine intake (DerocheGamonet et al., 2004; Vanderschuren and Everitt, 2004; Belin et al., 2008) and determine whether ovBNST D1-LTP GABA is a key neurophysiological mechanism that represents a potential therapeutic target for human addiction.
